犬用ワクチンの世界市場レポート 2024年

犬用ワクチン市場規模は近年力強く成長しています。2023年の34億3,000万米ドルから2024年には36億4,000万米ドルへと、CAGR6.2％で拡大します。過去数年間に見られた成長は、紙ベースの文書からデジタル文書への移行、規制遵守と記録管理の重視、企業のデジタル化イニシアティブ、文書画像化とスキャニング技術の採用、エンタープライズコンテンツ管理（ECM）ソリューションの登場といった要因によるものです。

アジア太平洋は、2023年の犬用ワクチン市場において最大の地域でした。犬用ワクチン市場レポートの対象地域は、アジア太平洋、西欧、中東欧、北米、南米、中東・アフリカです。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

• 高インフレが市場に与える影響
• ウクライナ・ロシア戦争が市場に与える影響
• COVID-19による市場への影響

第5章 世界市場規模と成長

• 世界の犬用ワクチン市場の促進要因と抑制要因
  • 市場促進要因
  • 市場抑制要因
• 世界の犬用ワクチンの市場規模実績と成長率、2018～2023年
• 世界の犬用ワクチン市場規模と成長予測、2023～2028年、2033年

第6章 市場セグメンテーション

• 世界の犬用ワクチン市場、タイプ別セグメンテーション、実績と予測、2018～2023年、2023～2028年、2033年
• 弱毒生ワクチン
• 結合型ワクチン
• 不活化ワクチン
• サブユニットワクチン
• トキソイドワクチン
• DNAワクチン
• 組換えワクチン
• 世界の犬用ワクチン市場、投与経路別セグメンテーション、実績と予測、2018～2023年、2023～2028年、2033年
• 皮下
• 筋肉内
• 鼻腔内
• 世界の犬用ワクチン市場、用途別セグメンテーション、実績と予測、2018～2023年、2023～2028年、2033年
• 6か月以下
• 6か月以上

第7章 地域と国の分析

• 世界の犬用ワクチン市場、地域別、実績と予測、2018～2023年、2023～2028年、2033年
• 世界の犬用ワクチン市場、国別、実績と予測、2018～2023年、2023～2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 犬用ワクチン市場の競合情勢
• 犬用ワクチン市場の企業プロファイル
  • Bayer AG
  • Vetoquinol SA
  • Boehringer Ingelheim GmbH
  • Ceva Sante Animale
  • Heska Corporation

第31章 競合ベンチマーキング

第32章 競合ダッシュボード

第33章 主要な合併と買収

第34章 将来の展望と潜在性分析

第35章 付録

Dog Vaccines Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on dog vaccines market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
• Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
• Measure the impact of high global inflation on market growth.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for dog vaccines? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The dog vaccines market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

• 1) By Type: Attenuated Live Vaccines; Conjugate Vaccines; Inactivated Vaccines; Subunit Vaccines; Toxoid Vaccines; DNA Vaccines; Recombinant Vaccines
• 2) By Route Of Administration: Subcutaneous; Intramuscular; Intranasal
• 3) By Application: Below 6 Months; Above 6 Months
• Companies Mentioned: Bayer AG; Vetoquinol S.A.; Boehringer Ingelheim GmbH; Ceva Sante Animale; Heska Corporation
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Dog vaccines constitute a series of administered injections, commencing during the puppy stage and extending into adulthood. These vaccines aim to introduce small amounts of a virus particle to trigger an immune response in the dog's body. This proactive measure enables the dog to mount an immune defense in the event of exposure to bacteria or viruses, thereby preventing illness.

Key categories of dog vaccines encompass attenuated live vaccines, conjugate vaccines, inactivated vaccines, subunit vaccines, toxoid vaccines, DNA vaccines, and recombinant vaccines. Attenuated live vaccines involve creating a vaccine by reducing the virulence of a pathogen while maintaining its viability. Administration methods include subcutaneous, intramuscular, and intranasal routes, catering to dogs below 6 months and those above 6 months.

The dog vaccines market research report is one of a series of new reports from The Business Research Company that provides dog vaccines market statistics, including dog vaccines industry global market size, regional shares, competitors with an dog vaccines market share, detailed dog vaccines market segments, market trends and opportunities, and any further data you may need to thrive in the dog vaccines industry. This dog vaccines market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The dog vaccines market size has grown strongly in recent years. It will grow from $3.43 billion in 2023 to $3.64 billion in 2024 at a compound annual growth rate (CAGR) of 6.2%. The growth observed in the historical period can be attributed to factors such as the shift from paper-based to digital documentation, a focus on regulatory compliance and records management, corporate digitization initiatives, the introduction of document imaging and scanning technologies, and the emergence of enterprise content management (ECM) solutions.

The dog vaccines market size is expected to see strong growth in the next few years. It will grow to $4.76 billion in 2028 at a compound annual growth rate (CAGR) of 6.9%. The anticipated growth in the forecast period can be attributed to the adoption in emerging markets and small to medium enterprises (SMEs), a heightened focus on user experience and mobile accessibility, migration to hybrid and cloud-centric models, an increase in data security concerns, and a growing demand for remote work solutions. Major trends in the forecast period encompass the integration with business applications, an emphasis on remote work and collaboration tools, the implementation of blockchain technology, the adoption of mobile-friendly interfaces, and a focus on cybersecurity and compliance in document management solutions.

The dog vaccines market is set for growth, fueled by the increasing adoption of pet dogs. Pet dogs, serving as domesticated companion animals, are becoming integral members of households. Dog vaccines, administered in a series from puppyhood into adulthood, stimulate the immune system, enabling dogs to resist microorganisms and exhibit either no illness or less severe symptoms. According to the National Pet Owners Survey by the American Pet Products Association for 2021-2022, 70% of U.S. households, equivalent to 90.5 million homes, owned pets. Notably, 69 million U.S. households embraced dogs as pets, representing the highest ownership compared to other animals. This surge in pet dog adoption is a key driver for the growth of the dog vaccines market.

The dog vaccines market is anticipated to witness growth due to the escalating prevalence of zoonotic diseases. Zoonotic diseases, capable of transmission between animals and humans, necessitate preventive measures. Dog vaccines play a crucial role in averting the transmission of zoonotic diseases from dogs to humans, contributing to broader public health initiatives. A report by the Council on Foreign Relations in February 2023 highlighted that up to 75% of newly discovered infectious diseases and 60% of recognized infectious diseases have zoonotic origins. These zoonoses cause significant global health concerns, resulting in millions of fatalities and disease episodes annually. The growing prevalence of zoonotic diseases is a driving factor for the dog vaccines market.

Technological advancements are emerging as a prominent trend in the dog vaccines market. Leading companies in the market are leveraging novel technologies for vaccine development. Merck Animal Health, a notable player, introduced Nobivac Intra-Trac Oral BbPi in September 2022. This oral vaccine, featuring mucosal protection and easy administration, represents a technological leap forward. It employs the innovative Immuno-Mist-R technology by Intervet, a Merck & Co subsidiary, significantly enhancing mucosal surface area contact. This technological progress in vaccine development contributes to the effectiveness and ease of administration in the dog vaccines market.

Major companies in the dog vaccines market are concentrating on innovative rabies vaccines to gain a competitive edge. The introduction of a three-dose rabies vaccine by Cadila Pharmaceuticals exemplifies this focus on innovation. Launched in April 2022, ThRabis is a recombinant nanoparticle-based rabies G protein vaccine, utilizing virus-like particle technology. The vaccine, generated from cloned genes expressed in insect cells, neutralizes the rabies virus and prevents its attachment to cells. This innovation in rabies vaccines addresses key aspects of effectiveness, accessibility, and administration, positioning companies at the forefront of the competitive landscape in the dog vaccines market.

In January 2021, Boehringer Ingelheim, a prominent Germany-based pharmaceutical company with an extensive portfolio of pharmaceutical products, including animal vaccines, entered into a partnership with PetMedix. The collaboration aims to develop new and transformative antibody therapeutics for companion animals, leveraging PetMedix's proprietary Ky9 platform. In this joint effort, PetMedix is responsible for the discovery of therapies against key targets, while Boehringer Ingelheim undertakes the development and commercialization of these therapies. PetMedix, a UK-based developmental-stage veterinary biopharmaceutical company, brings innovation to veterinary medicine through its Ky9TM platform, capable of rapidly and efficiently generating fully canine therapeutic antibodies. The collaboration signifies Boehringer Ingelheim's commitment to advancing veterinary medicine and expanding its offerings in the field of companion animal healthcare.

Major companies operating in the dog vaccines market report are Bayer AG, Vetoquinol S.A., Boehringer Ingelheim GmbH, Ceva Sante Animale, Heska Corporation, Merck & Co. Inc., Virbac Animal Health Pvt. Ltd., Elanco Animal Health Incorporated, Zoetis Inc., CZ Vaccines, Indian Immunologicals Ltd., Sanofi S.A., CyMedica Orthopedics Inc., Creative Biolabs Inc., Meiji Holdings Co. Ltd., Bioveta A.S., Phibro Animal Health Corporation, Hester Biosciences Limited, High Speed Digieal Processor Architecture Pvt. Ltd., Dechra Pharmaceuticals PLC, Idexx Laboratories Inc., Norbrook Inc., Biogenesis Bago SA, Vaxxinova India Private Limited, Bimeda Animal Health Ltd., Lohmann Animal Health GmbH, Biovac Ltd., Zenex Animal Health India Pvt. Ltd., Instituto Rosenbusch S A, and Pfizer Inc.

Asia-Pacific was the largest region in the dog vaccines market in 2023. The regions covered in the dog vaccines market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the dog vaccines market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The dog vaccines market consists of sales of vaccines for dogs including core dog vaccines, and non-core dog vaccines. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Table of Contents

1. Executive Summary

2. Dog Vaccines Market Characteristics

3. Dog Vaccines Market Trends And Strategies

4. Dog Vaccines Market - Macro Economic Scenario

• 4.1. Impact Of High Inflation On The Market
• 4.2. Ukraine-Russia War Impact On The Market
• 4.3. COVID-19 Impact On The Market

5. Global Dog Vaccines Market Size and Growth

• 5.1. Global Dog Vaccines Market Drivers and Restraints
  • 5.1.1. Drivers Of The Market
  • 5.1.2. Restraints Of The Market
• 5.2. Global Dog Vaccines Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
• 5.3. Global Dog Vaccines Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Dog Vaccines Market Segmentation

• 6.1. Global Dog Vaccines Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Attenuated Live Vaccines
• Conjugate Vaccines
• Inactivated Vaccines
• Subunit Vaccines
• Toxoid Vaccines
• DNA Vaccines
• Recombinant Vaccines
• 6.2. Global Dog Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Subcutaneous
• Intramuscular
• Intranasal
• 6.3. Global Dog Vaccines Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Below 6 Months
• Above 6 Months

7. Dog Vaccines Market Regional And Country Analysis

• 7.1. Global Dog Vaccines Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 7.2. Global Dog Vaccines Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Dog Vaccines Market

• 8.1. Asia-Pacific Dog Vaccines Market Overview
• Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Dog Vaccines Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.3. Asia-Pacific Dog Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.4. Asia-Pacific Dog Vaccines Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Dog Vaccines Market

• 9.1. China Dog Vaccines Market Overview
• 9.2. China Dog Vaccines Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.3. China Dog Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.4. China Dog Vaccines Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Dog Vaccines Market

• 10.1. India Dog Vaccines Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.2. India Dog Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.3. India Dog Vaccines Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Dog Vaccines Market

• 11.1. Japan Dog Vaccines Market Overview
• 11.2. Japan Dog Vaccines Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.3. Japan Dog Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.4. Japan Dog Vaccines Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Dog Vaccines Market

• 12.1. Australia Dog Vaccines Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.2. Australia Dog Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.3. Australia Dog Vaccines Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Dog Vaccines Market

• 13.1. Indonesia Dog Vaccines Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.2. Indonesia Dog Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.3. Indonesia Dog Vaccines Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Dog Vaccines Market

• 14.1. South Korea Dog Vaccines Market Overview
• 14.2. South Korea Dog Vaccines Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.3. South Korea Dog Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.4. South Korea Dog Vaccines Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Dog Vaccines Market

• 15.1. Western Europe Dog Vaccines Market Overview
• 15.2. Western Europe Dog Vaccines Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.3. Western Europe Dog Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.4. Western Europe Dog Vaccines Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Dog Vaccines Market

• 16.1. UK Dog Vaccines Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.2. UK Dog Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.3. UK Dog Vaccines Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Dog Vaccines Market

• 17.1. Germany Dog Vaccines Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.2. Germany Dog Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.3. Germany Dog Vaccines Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Dog Vaccines Market

• 18.1. France Dog Vaccines Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.2. France Dog Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.3. France Dog Vaccines Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Dog Vaccines Market

• 19.1. Italy Dog Vaccines Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.2. Italy Dog Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.3. Italy Dog Vaccines Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Dog Vaccines Market

• 20.1. Spain Dog Vaccines Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.2. Spain Dog Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.3. Spain Dog Vaccines Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Dog Vaccines Market

• 21.1. Eastern Europe Dog Vaccines Market Overview
• 21.2. Eastern Europe Dog Vaccines Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.3. Eastern Europe Dog Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.4. Eastern Europe Dog Vaccines Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Dog Vaccines Market

• 22.1. Russia Dog Vaccines Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.2. Russia Dog Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.3. Russia Dog Vaccines Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Dog Vaccines Market

• 23.1. North America Dog Vaccines Market Overview
• 23.2. North America Dog Vaccines Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.3. North America Dog Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.4. North America Dog Vaccines Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Dog Vaccines Market

• 24.1. USA Dog Vaccines Market Overview
• 24.2. USA Dog Vaccines Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.3. USA Dog Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.4. USA Dog Vaccines Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Dog Vaccines Market

• 25.1. Canada Dog Vaccines Market Overview
• 25.2. Canada Dog Vaccines Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.3. Canada Dog Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.4. Canada Dog Vaccines Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Dog Vaccines Market

• 26.1. South America Dog Vaccines Market Overview
• 26.2. South America Dog Vaccines Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.3. South America Dog Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.4. South America Dog Vaccines Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Dog Vaccines Market

• 27.1. Brazil Dog Vaccines Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.2. Brazil Dog Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.3. Brazil Dog Vaccines Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Dog Vaccines Market

• 28.1. Middle East Dog Vaccines Market Overview
• 28.2. Middle East Dog Vaccines Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.3. Middle East Dog Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.4. Middle East Dog Vaccines Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Dog Vaccines Market

• 29.1. Africa Dog Vaccines Market Overview
• 29.2. Africa Dog Vaccines Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.3. Africa Dog Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.4. Africa Dog Vaccines Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Dog Vaccines Market Competitive Landscape And Company Profiles

• 30.1. Dog Vaccines Market Competitive Landscape
• 30.2. Dog Vaccines Market Company Profiles
  • 30.2.1. Bayer AG
    • 30.2.1.1. Overview
    • 30.2.1.2. Products and Services
    • 30.2.1.3. Strategy
    • 30.2.1.4. Financial Performance
  • 30.2.2. Vetoquinol S.A.
    • 30.2.2.1. Overview
    • 30.2.2.2. Products and Services
    • 30.2.2.3. Strategy
    • 30.2.2.4. Financial Performance
  • 30.2.3. Boehringer Ingelheim GmbH
    • 30.2.3.1. Overview
    • 30.2.3.2. Products and Services
    • 30.2.3.3. Strategy
    • 30.2.3.4. Financial Performance
  • 30.2.4. Ceva Sante Animale
    • 30.2.4.1. Overview
    • 30.2.4.2. Products and Services
    • 30.2.4.3. Strategy
    • 30.2.4.4. Financial Performance
  • 30.2.5. Heska Corporation
    • 30.2.5.1. Overview
    • 30.2.5.2. Products and Services
    • 30.2.5.3. Strategy
    • 30.2.5.4. Financial Performance

31. Global Dog Vaccines Market Competitive Benchmarking

32. Global Dog Vaccines Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Dog Vaccines Market

34. Dog Vaccines Market Future Outlook and Potential Analysis

• 34.1 Dog Vaccines Market In 2028 - Countries Offering Most New Opportunities
• 34.2 Dog Vaccines Market In 2028 - Segments Offering Most New Opportunities
• 34.3 Dog Vaccines Market In 2028 - Growth Strategies
  • 34.3.1 Market Trend Based Strategies
  • 34.3.2 Competitor Strategies

35. Appendix

• 35.1. Abbreviations
• 35.2. Currencies
• 35.3. Historic And Forecast Inflation Rates
• 35.4. Research Inquiries
• 35.5. The Business Research Company
• 35.6. Copyright And Disclaimer